Media

The Neurodegenerative Disorders Awareness Night at UCLA

The Risk and Benefits of the New Alzheimer’s Drug

The Uniqueness of Alzheimer's New Medication

Two Women on Mission to Raise Awareness in Latino Community

UCLA Develops New Alzheimer's Disease Therapeutic

Dr. Varghese John, Dr. Istvan Mody, and colleagues were highlighted in a UCLA article about their recent therapeutic development, targeting ...

UCLA’s New AI Tool May Help Identify People at Risk of Undiagnosed Alzheimer’s

Dr. Timothy Chang, UCLA neurologist, explained how early diagnosis is critical for patient care and access to new therapies and that AI could help identify..

Updates on Lecanemab

What Families Can Expect with the New FDA-Approved Alzheimer’s Medication, Leqembi

Watch Dr. Keith Vossel’s exclusive live interview with KNBC-LA, NBC Channel 4 News, about the FDA’s fully approved Alzheimer’s drug, Lecanemab....

What Is the New Alzheimer’s Disease Medication – and Who Should Get It?

What’s Next for Leqembi After A Full Approval by the FDA

Listen to Dr. Keith Vossel’s exclusive interview with KNX News Radio, about the FDA’s full approval of the first-in-class Alzheimer’s drug, Lecanemab....